MICHELLE ERNEST: Open Payments
NPI 1609218205 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 33 payments from 14 companies in 2025. Trend: 2023 $544 · 2024 $882 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $373 |
| ABBVIE INC. | 2 | $108 |
| Ardelyx, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Medtronic, Inc. | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $26 |
| AtriCure, Inc. | 1 | $24 |
| Seqirus USA Inc | 1 | $24 |
Products named: Wegovy, Ozempic, QULIPTA, IBSRELA, MOUNJARO, GEMTESA, Kerendia, VENASEAL.
Industry payments across GA — which companies pay providers there.
